Mitochondria-associated Endoplasmic Reticulum Membranes (mams) Involve in the Regulation of Mitochondrial Dysfunction and Heart Failure
Kai Zhang,Qionglin Zhou,Yu Guo,Linxi Chen,Lanfang Li
DOI: https://doi.org/10.1093/abbs/gmy044
IF: 3.7
2018-01-01
Acta Biochimica et Biophysica Sinica
Abstract:Both endoplasmic reticulum (ER) and mitochondria are fundamental organelles that coordinate high-order cell functions. ER is an extensive network of cisternae and microtubules, which stretches from the nuclear envelope to the cell surface in all eukaryotic cells. ER works as the site for protein synthesis and corrects post-translational ‘folding’ of proteins. ER also has the ability to transport proteins to their destination. Moreover, ER acts as a calcium ion (Ca) reservoir which can be activated by both electrical and chemical stimulation. Mitochondria contain two membranes that separate four distinct compartments, the outer mitochondrial membrane, the intermembrane space, the inner mitochondrial membrane, and the matrix. As a highly dynamic organelle, the steady-state of the entire mitochondrial network is maintained through constant fusion and fission, which is considered as mitochondrial dynamics. The dynamic balance of mitochondria between fusion and fission is the basis of the maintenance of many physiological activities in organisms, such as cell division, apoptosis, autophagy, and aging. At the same time, it also plays a major role in ATP production, Ca buffering, free radical scavenging, and mitochondrial DNA genetic process [1]. The ER is responsible for folding, transport, and degradation of proteins, whereas mitochondria are the center of energy production [2]. Mitochondria and ER actively communicate with each other to promote a variety of cellular events, such as material transfer and signal transduction [3]. ER and mitochondria have several contact sites, which are named as mitochondria-associated endoplasmic reticulum membranes (MAMs). MAMs are involved in various biological functions, including lipid metabolism, Ca signaling, inflammation, autophagy, and apoptosis [4]. Recent studies showed that the MAMs contain lipid and protein constituents. Proteins enriched at the MAMs can be classified as follows: (1) the signaling molecules of regulating Ca: inositol 1,4,5-trisphosphate (IP3) receptors, which act as Ca 2+ channels [5], are highly expressed at the MAMs. Bcl-2 regulates IP3 receptors and ER Ca storage [6]; (2) molecular chaperones, such as BiP and HSP70 [7]; (3) lipid enzymes, such as Akt (PKB), which belongs to serine/threonine kinase and is involved in glucose metabolism, cell proliferation, and apoptosis [8]; (4) membrane tethering or sorting proteins, such as phosphoacidic cluster sorting protein 2 (PACS-2), which regulates the lipid-synthesizing enzyme, and tethers MAMs to mitochondria [9]; (5) apoptosis-related proteins; (6) proteins involved in protein degradation, such as dynamin-related protein 1 (DRP1), which is the classic example to regulate mitochondrial fission [10] (Fig. 1). MAMs are closely related to neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease (AD). Area-Gomez et al. [11] demonstrated the enrichment of γ-secretase in MAMs, which mediates the amyloid precursor protein to generate Aβ and results in human familial AD. AD is a disorder of ER-mitochondrial hyperconnectivity. Parkinson’s makes a positive effect on the ER-mitochondria interaction, which results in enhancement of physical coupling between ER and mitochondria and favor of calcium transfer from the ER to the mitochondria following IP3 generating agonist [12] (Fig. 1). Furthermore, MAMs are associated with insulin resistance and β-cell dysfunction in type 2 diabetes mellitus (T2DM). MAMs could be an important hub for hormonal and nutrient signaling in the liver. ER-mitochondria miscommunication could participate in hepatic insulin resistance. Targeting MAM structure and function might be a novel strategy for the treatment of T2DM [13] (Fig. 1). MAMs also contribute to the development of cancers. In MAMs, IP3 is responsible for the Ca 2+ release in ER. Ca is a ubiquitous intracellular second messenger required for functional mitochondrial metabolism during uncontrolled proliferation of cancer cells. More and more proteins are proved to finely regulate Ca transfer from ER to mitochondria in cancers, including triplenegative breast cancer [14], colorectal cancer [15], cervical cancer [16], and liver cancer [13] (Fig. 1).